These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2899964)

  • 1. Induction of Epstein-Barr virus antigens by hydroxyurea.
    Nováková Z; Roubal J
    Acta Virol; 1988 Mar; 32(2):160-3. PubMed ID: 2899964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound "Dongxia wan".
    Huang P; Deng H; Zhao M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):128-30. PubMed ID: 11503041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
    Färber I; Klinger C; Wutzler P; Thiel KD; Reefschläger J; Herrmann G
    Acta Virol; 1987 Jan; 31(1):13-8. PubMed ID: 2883852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
    Fujiwara S
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
    Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
    J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter.
    Furukawa M; Sakashita H; Kamide M; Umeda R
    Auris Nasus Larynx; 1990; 17(1):49-54. PubMed ID: 2167654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
    Edson CM; Cohen LK; Henle W; Strominger JL
    J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.
    Kawanishi M; Ito Y
    Cancer Lett; 1980 Dec; 11(2):129-32. PubMed ID: 6257378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
    Roubal J; Luka J; Klein G
    Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of actinomycin D and cycloheximide on Epstein-Barr virus early antigen induction in lymphoblastoid cells.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    J Gen Virol; 1980 Dec; 51(Pt 2):255-61. PubMed ID: 6262437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.